Imatinib-associated hyperpigmentation, a side effect that should be recognized

J Eur Acad Dermatol Venereol. 2009 Jan;23(1):82-3. doi: 10.1111/j.1468-3083.2008.02706.x. Epub 2008 Apr 1.
No abstract available

Publication types

  • Letter

MeSH terms

  • Antineoplastic Agents / adverse effects*
  • Antineoplastic Agents / therapeutic use
  • Benzamides
  • Female
  • Humans
  • Imatinib Mesylate
  • Leukemia, Myelogenous, Chronic, BCR-ABL Positive / drug therapy*
  • Middle Aged
  • Pigmentation Disorders / chemically induced*
  • Piperazines / adverse effects*
  • Piperazines / therapeutic use
  • Pyrimidines / adverse effects*
  • Pyrimidines / therapeutic use

Substances

  • Antineoplastic Agents
  • Benzamides
  • Piperazines
  • Pyrimidines
  • Imatinib Mesylate